Personalizing Treatment for Acute Alcoholic Hallucinosis: Clinical Utility of Integrated Pharmacogenetic Testing, Metabolic Phenotyping, and microRNA Biomarkers
A multi-omics approach synergistically optimizes antipsychotic therapy by addressing genotyping limitations through dynamic phenotyping and microRNA-based prognostication, significantly enhancing safety in this high-risk population.
Authors
- Igor Shatokhin
- Valentin Y. Skryabin
- Svetlana Sokolova
- Polina Makartseva
- Valentina Ivanchenko
- Anton Masyakin
Institutions
- Moscow Clinical Scientific Center (RU)
- Moscow School of Social and Economic Sciences (RU)
- Moscow Research and Clinical Center for Neuropsychiatry (RU)
- Research Center of Neurology (RU)
Publication Details
- Journal
- Psychopharmacology Bulletin
- Published
- 2025-12-22
- DOI
- https://doi.org/10.64719/pb.15425
- Primary Topic
- Alcoholism and Thiamine Deficiency
- Type
- article
- Field-Weighted Citation Impact
- 0.00